Seth Karol
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Seth Karol as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06533748 · Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and LymphomaSt. Jude Children's Research Hospital · recruiting · Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma · principal investigator
- Ph3NCT05183035 · Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)PedAL BCU, LLC · active not recruiting · Acute Myeloid Leukemia · principal investigator
- Ph1NCT04898894 · Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaSt. Jude Children's Research Hospital · active not recruiting · Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse, Refractory Acute Leukemia of Ambiguous Lineage · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic LeukemiaK08CA250418 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2020 to 2024 · $224,070 awarded in 2024Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:16 UTC. The ranking covers the 200 most relevant of 16 PubMed records, and a shared surname and initials can bring in a namesake. All 16 on PubMed
- Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.Lancet Oncol · 2020143 citationsRCR 6.5
- 59 citationsRCR 2.3
- Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.Blood Adv · 202259 citationsRCR 3.6
- 29 citationsRCR 0.8
- Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.J Natl Cancer Inst · 202121 citationsRCR 1.1
- 18 citationsRCR 4.0
- Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.Pediatr Blood Cancer · 202515 citationsRCR 3.4
- Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia.Blood Adv · 202313 citationsRCR 1.3
- Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia.JAMA Netw Open · 202413 citationsRCR 1.8
- Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia.Leukemia · 202311 citationsRCR 0.9